Dyne Therapeutics Market Sentiment

Dyne Therapeutics Inc

DYNNASDAQ

Trade with Public

$16.07

-0.20-1.23%

Últ. Act.: Oct 22, 4:21 AM

$16.40

0.130.8%

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivo FinanzasSentimientoPropiedad Comparar Opciones Informe de acciones

Dyne Therapeutics Market Sentiment - Benzinga

Dyne Therapeutics Market Sentiment

Market sentiment signals for Dyne Therapeutics (DYN): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Outperform

Short Interest▼ 17.8% short float

Options Flow— N/A

Insider Activity▲ Net Buyer (30d)

Analyst Consensus

Outperform

23 analysts

Options Flow (P/C)

—

Avg Consensus PT

$38

+131.7%

Highest Price Target

$56

+241.5%

Raymond James

Lowest Price Target

$10

-39.0%

JP Morgan

Short Interest

17.8%

Rising — Bearish

Insider Activity (30d)

Net Buyer

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 30, 2026	Chardan Capital	Keay Nakae—	+131.7%	$38 → $38	Maintained	Buy
Sep 30, 2026	HC Wainwright & Co.	Ananda Ghosh—	+95.1%	$50 → $32	Maintained	Buy
Sep 29, 2026	Piper Sandler	Edward Tenthoff—	+186.6%	$47 → $47	Maintained	Overweight
Sep 9, 2026	Morgan Stanley	Michael Ulz—	+119.5%	$45 → $36	Maintained	Overweight
Sep 9, 2026	JP Morgan	Tessa Romero—	-39.0%	$17 → $10	Downgrade	Neutral→Underweight
Sep 9, 2026	RBC Capital	Luca Issi—	+82.9%	$35 → $30	Maintained	Outperform
Sep 9, 2026	Baird	Brian Skorney—	+58.5%	$30 → $26	Maintained	Outperform
Jul 31, 2026	Morgan Stanley	Michael Ulz—	+174.4%	$47 → $45	Maintained	Overweight
Jul 30, 2026	RBC Capital	Luca Issi—	+113.4%	$30 → $35	Maintained	Outperform
Jul 23, 2026	Cantor Fitzgerald	Eric Schmidt—	—	—	Initiate	Overweight
Jun 26, 2026	TD Cowen	Joseph Thome—	—	—	Initiate	Buy
May 15, 2026	Evercore ISI Group	Gavin Clark-Gartner—	+101.2%	$34 → $33	Maintained	Outperform
May 13, 2026	Bernstein	William Pickering—	+46.3%	$23 → $24	Maintained	Market Perform
Mar 9, 2026	Chardan Capital	Keay Nakae—	+131.7%	$38 → $38	Maintained	Buy
Mar 3, 2026	Morgan Stanley	Michael Ulz—	+186.6%	$50 → $47	Maintained	Overweight
Mar 3, 2026	Chardan Capital	Keay Nakae—	+131.7%	$38 → $38	Maintained	Buy
Mar 3, 2026	HC Wainwright & Co.	Ananda Ghosh—	+204.9%	$60 → $50	Maintained	Buy
Jan 20, 2026	JP Morgan	Tessa Romero—	-2.4%	$17 → $16	Maintained	Neutral
Dec 15, 2025	Evercore ISI Group	Gavin Clark-Gartner—	+119.5%	$38 → $36	Maintained	Outperform
Dec 11, 2025	Stifel	Paul Matteis—	+137.8%	$36 → $39	Maintained	Buy
Dec 10, 2025	Oppenheimer	Andreas Argyrides—	+143.9%	$11 → $40	Upgrade	Perform→Outperform
Dec 9, 2025	Morgan Stanley	Michael Ulz—	+204.9%	$46 → $50	Maintained	Overweight
Dec 9, 2025	Chardan Capital	Keay Nakae—	+131.7%	$38 → $38	Maintained	Buy
Dec 8, 2025	HC Wainwright & Co.	Ananda Ghosh—	+265.9%	$46 → $60	Maintained	Buy
Nov 14, 2025	JP Morgan	Tessa Romero—	+3.7%	$18 → $17	Maintained	Neutral